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Abstract Five new guanacastane-type diterpenes, named guanacastepenes P–T (1–5), were isolated from cultures of the
fungus Psathyrella candolleana. Their structures were elucidated on the basis of extensive spectroscopic methods. All of
the compounds were tested for their 11b-hydroxysteroid dehydrogenase (11b-HSD1) inhibitory activity. Compound 3
exhibited inhibitory activity against both human and mouse isozymes of 11b-HSD1 with IC50 values of 6.2 and 13.9 lM,
respectively.
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1 Introduction
Guanacastepene A, was the first member of the guana-
castane family isolated from an unidentified endophytic
fungus (CR 115) [1]. This was followed by isolation of
guanacastepenes B–O from the same fungus by the same
group [2]. Heptemerones A–G were later isolated from
cultures of Coprinus heptemerus [3, 4], as well as radi-
anspenes A–M from Coprinus radians [5], which attracted
interest of the guanacastanes in the synthetic organic
community [6–18]. The total synthesis of guanacastepenes
with a novel 5/7/6 ring system was considered a chal-
lenging synthetic target [19], whereas synthesis of ana-
logues offered the best prospects for capitalizing on the
promising antibiotic activity, as well as avoiding the side
effect of hemolytic activity against human red blood cells
[10, 20]. However, no other bioactivities, except for
antibiotic effects were reported for this type of diterpenes.
As a part of a search for naturally occurring secondary
metabolites with diverse structures from higher fungi in
China, investigations of chemical components from Psa-
thyrella candolleana cultures were carried out, which led
to the isolation of a series of new guanacastane-type
diterpenes, guanacastepenes P–T (1–5, Fig. 1). Their
structures were elucidated by means of spectroscopic
methods. These compounds shared a larger conjugated
system including an a,b-unsaturated ketone moiety in the
highly oxygenated five-member ring system comparing to
the known guanacastane-type diterpenes. All of these
compounds were evaluated for their cytotoxic and anti-
herpes simplex viruses (HSV) activities, while compounds
1, 3, and 5 were evaluated for inhibitory activities against
one isozyme of 11b-hydroxysteroid dehydrogenases (11b-
HSD1).
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2 Results and Discussion
Guanacastepene P (1) was obtained as a light yellow oil. Its
molecular formula C20H28O3 was established from the
positive ion HRESIMS ([M?Na]?, 339.1930), indicating 7
degrees of unsaturation. The 13C NMR (DEPT) spectrum
suggested 20 carbon resonances (Table 2), classified as five
methyl groups, four aliphatic methylenes, three methines
(one olefinic and one oxygenated), and eight quaternary
carbons (one carbonyl and five olefinic). Thus, four degrees
of unsaturation were accounted for by the three double
bonds and the one carbonyl group, while the remaining
three degrees of unsaturation suggested that compound 1
should possess a three-ring system. Further inspection of
the 1H NMR spectrum and 1H–1H COSY correlations
(Fig. 2) resulted in the deduction of an isopropyl group
(Me-19–H-18–Me-20), two connected methylene groups
(H2-9–H2-10), a chain of CH2–CH2–CH–OH (H2-7–H2-6–
H-5–OH), an isolated olefinic hydrogen (H-2), and three
isolated methyl groups (H-15, H-16 and H-17).
Connectivity among the above mentioned fragments and
the contribution of the three-ring system were established
by analysing 1H, 13C long-range correlations extracted
from HMBC experiments (Fig. 2). The correlations of
H-18 to C-11, C-12 and C-13 and HO-13 to C-12 and C-14
established the connection of C-11–C-12–C-13–C-14,
while the correlations of H-17 to C-11, C-12 and C-1, and
H-2 to C-1 and C-11 indicated the presence of a five-
membered ring A. Subsequently, the correlations of H-9 to
C-8 and H-10 to C-11 supported the connection of C-8–C-
9–C-10–C-11. Besides, correlations of H-16 to C-8 and
C-3, as well as H-2 to C-8 were evident for a seven-
membered ring B. The last ring C and the links of
remaining blocks were clearly shown by HMBC correla-
tions of H-15 to C-3, C-4 and C-5, H-5 to C-4 and C-6, H-6
to C-4 and C-5, and H-7 to C-8 and C-3. Finally, compound
1 possessed a backbone of a 5/7/6 ring system related to
that of guanacastepene A [1]. Biogenetically, the stereo-
configurations of methyls of Me-16 and Me-17 were a and
b oriented, respectively [4]. In the ROESY spectrum (Fig.
3), correlations between H-17, H-9b and H-10b were
observed, suggesting both were b oriented, while correla-
tions of H-5/H-6a, and H-6a/H-16 indicated that H-5 was a
oriented.
Guanacastepene Q (2), purified as a light yellow oil, had
a molecular formula of C20H26O3 according to its HRE-
SIMS at m/z 315.1962 ([M?H]?). The 13C NMR (Table 2)
spectroscopic data were similar to those of compound 1.
The main difference was that an oxygenated methine at dC
70.3 (C-5) in 1 was replaced by a keto carbonyl group at dC
197.5 in 2, constructing a 3,4-unsaturated-5-keto moiety,
which led to the downfield shift of C-3 (Dd 20.8 ppm) and
C-6 (Dd 4.4 ppm), and the upfield shift of C-4 (Dd
6.4 ppm) in compound 2, consistent with the HMBC cor-
relations of H-6, H-7 and H-15 to C-5. Detailed analysis of
1D and 2D NMR data (HSQC, HMBC, 1H–1H COSY,
ROESY) suggested that the other parts of 2 were the same
as those of 1. Therefore, compound 2 was established as
shown.
Guanacastepene R (3), a light yellow oil, had a molec-
ular formula of C20H26O4 on the basis of its HRESIMS at
m/z 353.1737 ([M?Na]?), 16 mass units higher than that of
2. The 1D NMR spectroscopic data (Tables 1 and 2) were
quite similar to those of 2, except that the signals for a
methyl group in 2 were replaced by the signals for an
oxygenated methylene group, which was confirmed by the
HMBC correlations of dH 3.62 (1H, d, J = 7.0 Hz, OH-15)
to dC 56.4 (t, C-15) and dC 136.3 (s, C-4). Careful analysis
of the spectroscopic data finally established the structure of
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Fig. 2 1H–1H COSY and HMBC correlations for 1 and 5
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Guanacastepene S (4) had the same molecular formula
of C20H28O3 (HRESIMS ([M?Na]
? at m/z 339.1927) as 1
and was obtained as a colorless oil. Its 13C NMR spectrum
(Table 2) displayed 20 carbon signals corresponding to five
methyls (three singlets and two doublets), five methylenes,
two methines and eight quaternary carbons (four olefinic
and two carbonyl carbons), consistent with a similar
structure of compound 2. Significant differences were one
less double bond and absence of an olefinic hydrogen in 4.
The H-18 correlation with a methine proton at dH 1.97 (1H,
d, J = 2.7 Hz, H-12) in the 1H–1H COSY spectrum, and the
key HMBC correlations of the OH signal at dH 7.84 (1H,
br. s, OH-14) to a keto carbonyl carbon dC 202.9 (s, C-13)
and the double bond signal at dC 148.1 (s, C-14) indicated a
different enolization of the 13,14-diketone system (to a
13-keto-14-enol) in 4. Further analysis of 2D NMR spec-
troscopic data suggested that the other parts were the same
to those of 2, except the olefinic carbon at C-2 in 2 being
replaced by a methylene moiety in 4, as established by the
HMBC correlations of dH 3.50 and 3.60 (each 1H, d, J =
19.0 Hz, H-2) to C-1. On the basis of the ROESY exper-
iment, H-12 was elucidated to be a oriented by correlations
of H-17 with H-18 and H-19. Thus compound 4 was
assigned as guanacastepene S.
Guanacastepene T (5) possessed the molecular formula
C20H30O3, as determined by its HRESIMS at m/z 341.2091
([M?Na]?), indicating six degrees of unsaturation. The
13C NMR spectroscopic data (Table 2) together with ana-
lysis of its HSQC spectrum indicated 20 carbons, including
four methyls, five methylenes (one olefinic), six methines
(two oxygenated and one olefinic), and five quaternary
carbons (two olefinic and one carbonyl carbons). Com-
prehensive analysis of the 1H–1H COSY and HMBC
spectra (Fig. 2), suggested that 5 shared the same
Table 1 1H NMR [dH (mult, J (Hz))] spectroscopic data (400 MHz) for guanacastepenes P–T (1–5)
No. 1a 2a 3a 4a 5b
1
2 6.90, br. s 6.96, br. s 7.17, s 3.50, d (19.0)
3.66, d (19.0)
6.85, d (4.1)
3 3.43, br. s





2.35, dt (16.8, 4.8)
2.68, ddd (16.8, 13.1, 4.8)
2.37, dt (16.7, 4.9)
2.69, ddd (16.7, 13.2, 4.9)

















1.45, ddd (14.0, 4.4, 3.3)
2.21, td (14.0, 3.3)
1.59, dt (14.4, 3.1)
2.47, td (14.4, 3.1)
1.62, ddd (14.3, 4.4, 3.1)
2.48, td (14.0, 3.1)
1.80, overlapped
1.60, td (13.9, 3.5)
3.89, br.d (11.6)
10a 1.54, td (14.0, 3.3) 1.73, td (13.6, 3.1) 1.75, td (13.8, 3.1) 2.14, m 2.16, m
10b 1.84, ddd (14.0, 4.4, 3.3) 1.94, overlapped 1.95, overlapped 1.46, mc 1.74, overlappedc
12 1.97, d (2.7) 1.57, overlapped
13 2.47, dd (18.1, 7.6)
2.14, m
15 1.72, s 1.67, s 4.26, dd (11.9, 5.9)
4.11, dd (11.9, 5.9)
1.84, br.s 5.22, d (1.4)
5.11, d (1.4)
16 0.86, s 1.07, s 1.10, s 1.11, s 0.66, s
17 1.12, s 1.12, s 1.15, s 1.11, s 1.16, s
18 2.52, h (7.0) 2.54, h (7.1) 2.55, h (7.0) 2.07, m 1.82, m
19d 1.26, d (7.0) 1.30, d (7.1) 1.30, d (7.0) 1.14, d (6.9) 0.93, d (6.7)
20d 1.29, d (7.0) 1.28, d (7.1) 1.28, d (7.0) 0.84, d (6.9) 1.07, d (6.7)
5-OH 3.98, d (6.7)
13-OH 7.71, br. s 7.91, br. s 7.96, br. s
14-OH 7.84, br. s
15-OH 3.62, t (5.9)
a In Me2CO-d6
b In CDCl3
c Could not be assigned to a/b, signals overlapping
d Signals were exchangeable
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guanacastepene skeleton with 1, except for differences in
the number and location of functional groups. The 1H–1H
COSY correlations of H-19/H-18/H-12/H-13, combined
with HMBC correlations of H-13 with C-14, C-12 and C-1,
and H-2 with C-1 and C-14 suggested the presence of a
single 2(1)-en-14-one system in 5. Besides, the trisubsti-
tuted double bond between C-3 and C-4 in 1 was changed
into a terminal double bond between C-4 and C-15 in 5,
consistent with the 1H NMR chemical shifts of dH 5.11 and
5.22 (each 1H, br. s, H-15), which was also supported by
the HMBC correlations of H-15 to C-3 and C-4, and H-3 to
C-2 and C-4. The 1H–1H COSY data, as well as HMBC
correlations of H-5 to C-3 and C-15 also gave the infor-
mation that C-5 was a methine substituted by a hydroxy
group. Likewise, C-9 was confirmed as a hydroxy substi-
tuted methine based on the 1H–1H COSY and HMBC
correlations as shown in Fig. 2. Based on the proposed
biogenetic orientation of Me-16 and Me-17, the configu-
rations of H-3 and HO-9 were determined to be b and a
oriented, respectively, owing to the strong correlation sig-
nals of H-3 with H-17 and H-9, and H-9 with H-17 in the
ROESY spectrum. In addition, the stereoconfiguration of
H-5 was determined to be a oriented, as indicated by the
observation of the ROESY correlations the same to those
of compound 1. Consequently, compound 5 was elucidated
as guanacastepene T.
Compounds 1–5 were evaluated for their cytotoxicity
against five human cancer cell lines. None was found to
possess significant activity with IC50 values less than
40 lM. In addition, they were evaluated for anti-HSV
(herpes simplex viruses) activity. However, none exhibited
activity. Furthermore, compounds 1, 3 and 5 were tested
for inhibitory activities against one isozyme of 11b-HSD1.
Of these, only compound 3 exhibited inhibitory activity
against both human and mouse isozymes of 11b-HSD1
with IC50 values of 6.2 and 13.9 lM, while glycyrrhizinic
acid (positive control) had IC50 values of 4.2 and 6.5 nM,
respectively.
Five new guanacastane-type diterpenes, guanacastep-
enes P–T, each containing a 5/7/6 ring system, were iso-
lated from cultures of fungus P. candolleana. Until now,
totally 33 guanacastane-type diterpenes have been obtained
from kinds of fungi, and some of them showed antibiotic
and antitumor activities. Our present research enriched the
structure diversity of the guanacastane family and this is
Not observed
Observed
Fig. 3 Key ROESY correlations of 1
Table 2 13C NMR data of
guanacastepenes P–T (1–5)
a Recorded at 150 MHz in
Me2CO-d6
b Recorded at 100 MHz in
Me2CO-d6
c Recorded at 150 MHz in
CDCl3
d Signals were exchangeable
No. 1a 2b 3a 4a 5c
1 141.6, qC 142.3, qC 143.1, qC 148.8, qC 147.5, qC
2 130.4, CH 127.9, CH 127.3, CH 30.3, CH2 134.2, CH
3 136.4, qC 157.2, qC 160.4, qC 160.5, qC 40.5, CH
4 139.1, qC 132.7, qC 136.3, qC 131.8, qC 148.6, qC
5 70.3, CH 197.5, qC 198.0, qC 197.5, qC 73.9, CH
6 29.7, CH2 34.1, CH2 34.3, CH2 34.2, CH2 30.0, CH2
7 38.0, CH2 38.9, CH2 38.9, CH2 39.9, CH2 31.5, CH2
8 36.7, qC 37.5, qC 37.8, qC 40.2, qC 44.3, qC
9 38.5, CH2 35.5, CH2 35.5, CH2 41.3, CH2 77.2, CH
10 30.9, CH2 30.7, CH2 30.8, CH2 36.1, CH2 43.7, CH2
11 44.7, qC 44.6, qC 44.7, qC 45.0, qC 44.0, qC
12 154.9, qC 155.7, qC 155.9, qC 62.0, CH 51.8, CH
13 151.0, qC 151.2, qC 151.3, qC 202.9, qC 41.3, CH2
14 189.1, qC 188.5, qC 188.5, qC 148.1, qC 205.2, qC
15 17.0, CH3 12.2, CH3 56.4, CH2 11.7, CH3 111.9, CH2
16 26.5, CH3 26.1, CH3 25.9, CH3 24.3, CH3 10.5, CH3
17 20.7, CH3 20.6, CH3 20.8, CH3 17.8, CH3 17.2, CH3
18 26.5, CH 26.5, CH 26.6, CH 28.1, CH 28.7, CH
19d 20.8, CH3 20.7, CH3 20.7, CH3 23.7, CH3 22.6, CH3
20d 20.8, CH3 20.7, CH3 20.7, CH3 19.2, CH3 24.3, CH3
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also the first report to show that guanacastane-type diter-
penes possessed inhibitory activity against human 11b-
HSD1.
3 Experimental
3.1 General Experimental Procedures
Optical rotations (OR) were recorded on a JASCO P-1020
digital polarimeter, while the UV and IR spectra were
obtained on a Shimadzu UV2401PC and a Bruker Tensor
27 FT-IR (KBr pellets) spectrometers. NMR spectra were
acquired on Bruker AM-400, DRX-500 and Avance III
600 MHz spectrometers with tetramethylsilane (TMS)
used as an internal standard at room temperature. High-
resolution (HR) ESI-MS were recorded on an API QSTAR
Pulsar spectrometer. Silica gel (200–300 mesh, Qingdao
Marine Chemical Ltd., People’s Republic of China) and
Sephadex LH-20 (Amersham Biosciences, Sweden) were
used for open column chromatography (CC). Preparative
HPLC was performed on an Agilent 1100 liquid chroma-
tography system equipped with a Zorbax SB-C18 column
(21.2 mm 9 150 mm). Fractions were monitored by TLC.
Spots were visualized by heating silica gel plates immersed
in vanillin–H2SO4 in EtOH.
3.2 Fungal Material and Cultivation Conditions
The fungus P. candolleana (Pers.) Fr. was collected at
Kunming Institute of Botany in Yunnan Province, People’s
Republic of China, in 2003. The fungus was identified by
Prof. Zhu-Liang Yang at the Kunming Institute of Botany.
A specimen (No. KIB20030828) was deposited at Kun-
ming Institute of Botany, Chinese Academy of Sciences.
Basidiomata small to medium-sized. Pileus 3–7 cm in
diam, campaniform then flattened, with moist umbonate
center; surface glabrous, light honey-yellow to brown,
yellow-brown at the apex, fading to grayish when dry;
white universal veil gradually fall off with age. Context
white, relatively thin. Lamellae adnate, narrow and length
unequal, crowded, dirty white, grayish to pallid purple-
brown; edge dirty white, coarse. Stipe slender and fistulous,
cylindrical, 3–8 9 0.2–0.7 cm, white, weak and fragile,
surface densely floccose-fibrillose or reticulate. Spores
print dark purple-brown; spores smooth, ellipsoid, 6.5–9.0
9 3.5–5.0 lm, germ pore was visible. Pleurocystidia
smooth and thin-walled, hyaline in KOH, more or less la-
geniform and apex rounded, 34–50 9 8–16 lm.
The culture medium consisted of glucose (5 %), peptone
from porcine meat (0.15 %), yeast powder (0.5 %),
KH2PO4 (0.5 %) and MgSO4. Fermentation was carried
out on a shaker at 160 RPM for 25 days.
3.3 Extraction and Isolation
The culture broth (21 L) was filtered, and the filtrate was
extracted with ethyl acetate (20 L 9 3), while the myce-
lium was extracted three times with CHCl3–MeOH (1:1).
The EtOAc layer together with the mycelium extract was
concentrated under reduced pressure to give a crude extract
(10 g), and the latter was applied to a silica gel column
eluted with a gradient of CHCl3/MeOH (1:0?0:1) to
obtain five fractions (1–5). Fraction 3 was subjected to
Sephadex LH-20 (CHCl3/MeOH 1:1) to give two sub-
fractions (3a–3b). Fraction 3a was separated by semipre-
parative HPLC (MeCN/H2O, 1:9?2:8, 30 min) to give
three mixtures, then purified separately by Sephadex LH-
20 CC (acetone) to give 2 (2.1 mg), 4 (2.0 mg) and 5
(4.8 mg), respectively. In the same way, subfraction 3b was
purified by semipreparative HPLC (MeCN/H2O, 1:9?2:8,
40 min) to yield 1 (3.1 mg) and 3 (3.3 mg).
3.4 Guanacastepene P (1)
Light yellow oil; ½a16D - 507.0 (c 0.70, MeOH); IR (KBr)
mmax 3444, 2925, 1632 cm
-1; UV (MeOH) kmax (log e) 307
(4.16), 206 (4.16); For 1H (400 MHz) and 13C NMR
(150 MHz) spectroscopic data (Me2CO-d6), see Tables 1
and 2; positive ion HRESIMS m/z 339.1930 (calcd for
C20H28O3Na [M?Na]
?, 339.1936).
3.5 Guanacastepene Q (2)
Light yellow oil; ½a16D - 318.3 (c 1.6, MeOH); IR (KBr)
mmax 3433, 2963, 2925, 1669, 1627, 1409, 1152 cm
-1; UV
(MeOH) kmax (log e) 289 (4.03), 236 (3.87), 203 (3.91); For
1H (400 MHz) and 13C NMR (100 MHz) spectroscopic
data (Me2CO-d6), see Tables 1 and 2; positive ion HRE-
SIMS m/z 315.1962 (calcd for C20H27O3 [M?H]
?,
315.1960).
3.6 Guanacastepene R (3)
Light yellow oil; ½a16D - 303.7 (c 1.9, MeOH); IR (KBr)
mmax 3433, 2924, 1630, 1104 cm
-1; UV (MeOH) kmax (log
e) 285 (3.99), 232 (3.82), 203 (3.93); For 1H (400 MHz)
and 13C NMR (150 MHz) spectroscopic data (Me2CO-d6),
see Tables 1 and 2; positive ion HRESIMS m/z 353.1737
(calcd for C20H26O4 [M?H]
?, 353.1728).
3.7 Guanacastepene S (4)
Colorless oil; ½a21D - 167.5 (c 1.9, MeOH); IR (KBr) mmax
3431, 2924, 2346, 1630 cm-1; UV (MeOH) kmax (log e)
285 (3.82), 201 (3.86); For 1H (400 MHz) and 13C NMR
Five New Guanacastane-Type Diterpenes 153
123
(150 MHz) spectroscopic data (Me2CO-d6), see Tables 1
and 2; positive ion HRESIMS m/z 339.1927 (calcd for
C20H28O3 [M?Na]
?, 339.1927).
3.8 Guanacastepene T (5)
Colorless oil; ½a21D ? 0.75 (c 0.8, MeOH); IR (KBr) mmax
3440, 2923, 1631 cm-1; UV (MeOH) kmax (log e) 252
(3.71), 201(3.52); For 1H (400 MHz) and 13C NMR
(150 MHz) spectroscopic data (CDCl3), see Tables 1 and




Human myeloid leukemia HL-60, hepatocellular carci-
noma SMMC-7721, lung cancer A-549 cells, breast cancer
MCF-7 and colon cancer SW480 cell lines were used in the
cytotoxic assay. All cell lines were cultured in RPMI-1640
or DMEM medium (Hyclone, USA), supplemented with
10 % fetal bovine serum (Hyclone, USA) in 5 % CO2 at 37
C. The cytotoxicity assay was performed according to the
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide[ method in 96-well microplates [21]. Briefly,
adherent cells (100 lL) were seeded into each well of
96-well cell culture plates and allowed to adhere for 12 h
before drug addition, while suspended cells were seeded
just before drug addition with initial density of 1 9 105
cells/mL. Each tumor cell line was exposed to the test
compound dissolved in DMSO at concentrations of 0.0625,
0.32, 1.6, 8, and 40 lM in triplicates for 48 h, with
cisplatin (Sigma, USA) as a positive control. After com-
pound treatment, cell viability was detected and a cell
growth curve was graphed. IC50 values were calculated by
Reed and Muench’s method [22].
3.10 Antiviral Assay
Confluent Vero cells in a 96-well tissue plate were inocu-
lated in triplicate with virus suspension (50 lL) [HSV/
Blue, at multiplicity of infection (MOI) 1] and culture
medium (50 lL) containing testing compounds at different
concentrations. Cells were lysed with 1 % Nonidet P-40 in
DMEM at 24 h postinfection. Lysates from each well were
mixed with chlorophenol red-b-D-galactopyranoside
[CPRG; Boehringer, Ingelheim, Germany), and b-galacto-
sidase (b-Gal)] activity was measured by taking absorbance
readings at 570 nm every 2 min for a total of 25 readings.
The slope of the line was used to quantify b-Gal activity as
milli-optical density units/min (mOD/min). The 50 %
inhibitory concentration (IC50) was defined as the con-
centration of the antiviral drug that reduced the mOD/min
values by 50 % relative to the virus control. Inhibitory
concentrations were calculated using the probit regression
method [23].
3.11 Inhibitory Activities Against 11b-HSD1 Assay
Inhibitory activities of the compounds on human or mouse
11b-HSD1 were determined using scintillation proximity
assay (SPA). Microsomes containing 11b-HSD1 were used
according to our previous studies [24, 25]. Full-length
cDNAs of human or murine 11b-HSD1 were isolated from
cDNA libraries provided by the NIH Mammalian Gene
Collection. The cDNAs were cloned into pcDNA3
expression vectors. HEK-293 cells were transfected with
the pcDNA3-derived expression plasmid and selected by
cultivation in the presence of G418 (700 lg/mL). The
microsomal fraction overexpressing 11b-HSD1 was pre-
pared from the HEK-293 cells, which were stable trans-
fected with 11b-HSD1. The fraction was then used as the
enzyme source for SPA. Microsomes containing human or
mouse 11b-HSD1 were incubated with NADPH and [3H]
cortisone. The product, [3H] cortisol, was specifically
captured by a monoclonal antibody coupled to protein
A-coated SPA beads. All tests were done in twice with
glycyrrhizinic acid as a positive control. IC50 (X ± SD, n =
2) values were calculated by using Prism Version 4
(GraphPad Software, San Diego, CA, USA).
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